Skip to main content

Month: April 2021

Vollständige Ergebnisse nach 72 Wochen der Phase-3-HOPE-Studie zu Oxbryta® (Voxelotor) Tabletten in The Lancet Haematology veröffentlicht – signifikante Verbesserung von Hämoglobin, Hämolyse und der allgemeinen Gesundheit bei Patienten mit Sichelzellkrankheit

SOUTH SAN FRANCISCO, Kalifornien, April 09, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) hat heute bekanntgegeben, dass The Lancet Haematology die vollständige Analyse der Daten nach 72 Wochen der Phase-3-HOPE-Studie zu Oxbryta® (Voxelotor) Tabletten für Patienten mit Sichelzellkrankheit (SZK) veröffentlicht hat. Die Ergebnisse zeigen eine signifikante und nachhaltige Verbesserung des Hämoglobinspiegels, eine Verringerung der Hämolyse und einen verbesserten allgemeinen Gesundheitszustand bei Patienten, die mit Oxbryta behandelt wurden. Die Ergebnisse stützen die langfristige Anwendung von Oxbryta zur Reduzierung hämolytischer Anämie und Hämolyse bei SZK, was die lebensbedrohlichen Komplikationen der Erkrankung potenziell verringern könnte. Oxbryta ist ein „first-in-class“, einmal täglich oral einzunehmendes...

Continue reading

IRADIMED CORPORATION to Hold 2021 First Quarter Financial Results Conference Call on April 30th

WINTER SPRINGS, Fla., April 09, 2021 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market opens on Friday, April 30th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-247-5767 for international callers, and entering reservation code 8386999. The conference call will also be available real-time via the Internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website for 90 days following completion of the call. About IRADIMED CORPORATION IRADIMED...

Continue reading

Iveda Enters Hospital Asset Management Industry with 2021 Artificial Intelligence Award Winner Claro Enterprise Solutions

MESA, Ariz, April 09, 2021 (GLOBE NEWSWIRE) — Iveda® (OTCMKTS:IVDA), worldwide provider of IvedaAITM intelligent video search technology, Sentir® Video surveillance products, IvedaPinpointTM and IvedaHomeTM IoT (Internet of Things) platforms with smart devices, today announced it has co-developed the 2021 Artificial Intelligence award-winning offering in Hospital Asset Management with Claro Enterprise Solutions. Claro is a leading global technology services company. The award was given by the Business Intelligence Group’s Artificial Intelligence Excellence Awards program The joint solution addresses hospital asset management challenges that include shrinkage, low equipment utilization, and the countless hours currently wasted by hospital staff trying to locate misplaced equipment. As a result, quality of care, patient experience,...

Continue reading

Kraken Enters into Letter of Intent to Acquire Subsea Services Company

ST. JOHN’S, Newfoundland, April 09, 2021 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF), Canada’s Ocean Company, is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) dated April 8, 2021 in connection with the proposed acquisition of PanGeo Subsea Inc. (“PanGeo”) from Cahill Innovation Inc, a member of the Cahill Group of Companies, and Argentum Asset Management AS. Moya Cahill, a director of Kraken, is a shareholder of Cahill Innovation Inc, and she resigned as a director of Kraken prior to the approval and execution of the LOI in order to ensure proper governance and review of the transaction by a fully arm’s length board. PanGeo is a private Canadian services company specializing in high resolution 3D acoustic imaging solutions for the sub-seabed. This proposed acquisition...

Continue reading

Luminosity Gaming Ranks as the World’s Most Watched Esports Organization on Twitch in March 2021

TORONTO, April 09, 2021 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX:EGLX) (OTCQB: ENGMF) (FSE:2AV), the largest gaming media platform in North America, reaching over 300 million monthly video game and esports fans worldwide, is thrilled to announce its esports organization, Luminosity Gaming, was ranked by Streams Charts as the most popular esports community on Twitch in March 2021, with 40 million hours watched, outpacing the runner up by more than 15 million hours. Luminosity takes the top spot from number 2 in February. “The surging popularity of Luminosity is a testament to the incredible talent of our players and creators, as well as the loyalty of our fans,” commented Adrian Montgomery, CEO of Enthusiast Gaming. “Luminosity Gaming is a strategic asset and a critical...

Continue reading

TELUS invests $2 million in the Mékinac and des Chenaux RCMs, expanding its PureFibre and 5G networks

Our investments provide families and businesses with direct access to PureFibre, using the fastest and most reliable Internet technology in the world TELUS enhances wireless coverage with the deployment of 5G and a new cell tower in Saint-Adelphe SAINT-TITE, Quebec, April 09, 2021 (GLOBE NEWSWIRE) — TELUS is investing nearly $2 million in the Mékinac and des Chenaux RCMs (Regional county municipalities) in 2021 and will accelerate the deployment of its PureFibre and 5G networks to bridge the digital divide, drive innovation in businesses and grass-roots charities, and support the health, agriculture and education sectors. “Our 6,000 team members across the province are committed to actively continuing the deployment of our networks across Quebec, and driving the economic recovery of our regions,” says Marie-Christine D’Amours, Vice...

Continue reading

TELUS investit 2 millions de dollars dans les MRC de Mékinac et des Chenaux et déploie ses réseaux PureFibre et 5G

Nos investissements permettent aux familles et entreprises d’avoir accès au réseau PureFibre qui utilise la technologie Internet la plus rapide et fiable au monde TELUS bonifie la couverture sans fil avec le déploiement de la 5G et l’ajout d’un site de télécommunication à Saint-Adelphe SAINT-TITE, Québec, 09 avr. 2021 (GLOBE NEWSWIRE) — TELUS investit plus de 2 millions de dollars les MRC de Mékinac et des Chenaux en 2021 et accélère le déploiement de ses réseaux PureFibre et 5G afin de combler les fossés numériques en stimulant l’innovation des entreprises, des organismes locaux et des secteurs de la santé, de l’agriculture et de l’éducation. « Nos 6 000 membres de l’équipe de la province sont engagés à poursuivre activement le déploiement de nos réseaux aux quatre coins du Québec, et à participer à la relance économique...

Continue reading

COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference

London, UK, April 09, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that George Goldsmith, Chairman, CEO and Co‑founder, and Lars Wilde, President, Chief Business Officer, and Co‑founder, will present a corporate update at 8:00am ET on 15 April at the 20th Annual Needham Virtual Healthcare Conference. Members of the COMPASS management team will also be holding 1:1 investor meetings.   A live audio webcast of the presentation will be available on the “Events” page of the Investors section of the COMPASS website. A replay of the webcast will be available for 30 days following the event. For more information, please visit ir.compasspathways.com. -Ends- About COMPASS Pathways COMPASS...

Continue reading

Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During American Association for Cancer Research (AACR) 2021 Annual Meeting

Median Duration of Response Not Reached at 28.1 Months of Median Study Follow Up in Cohort 2 of C-144-01 Study 36.4% Overall Response Rate; Continued Deepening of Responses SAN CARLOS, Calif., April 09, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced data from Cohort 2 in the C-144-01 study of lifileucel in advanced melanoma. These data will be part of an oral presentation in a Clinical Trials Plenary Session at the upcoming American Association for Cancer Research (AACR) 2021 Annual Meeting. “We are very excited to report our latest Cohort 2 melanoma data in an oral presentation at AACR,” said Maria Fardis, Ph.D., President and Chief Executive Officer of Iovance Biotherapeutics. “The long term follow up...

Continue reading

F-Secure Corporation – Manager’s Transactions – Päivi Rekonen

F-Secure Corporation, Stock Exchange Release, 9 April 2021, at 14.00 EEST F-Secure Corporation – Manager’s Transactions – Päivi Rekonen F-Secure Oyj – Managers’ Transactions____________________________________________ Person subject to the notification requirementName: Rekonen, PäiviPosition: Member of the Board/Deputy memberIssuer: F-Secure OyjLEI: 743700ATXLT0MFCHXT16 Notification type: INITIAL NOTIFICATIONReference number: 743700ATXLT0MFCHXT16_20210408130059_2____________________________________________ Transaction date: 2021-04-07Venue not applicableInstrument type: SHAREISIN: FI0009801310Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION Transaction details(1): Volume: 4,966 Unit price: EUR Aggregated transactions(1): Volume: 4,966 Volume weighted average price: EUR Contact information: Henri...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.